{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:07:42Z","timestamp":1778936862863,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01 AI141576\\u201301"],"award-info":[{"award-number":["K01 AI141576\\u201301"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1088264"],"award-info":[{"award-number":["OPP1088264"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AI007524"],"award-info":[{"award-number":["T32AI007524"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacig.2023.100092","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:47:03Z","timestamp":1679024823000},"page":"100092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-5965","authenticated-orcid":false,"given":"Justin R.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Laufer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Brunwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flanon","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatoumata","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deshayne B.","family":"Fell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadima C.","family":"Haidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina V.","family":"Hartert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama M.","family":"Keita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Neuzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney M.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samba","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan C.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10098","key":"10.1016\/j.jacig.2023.100092_bib1","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100092_bib2","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.vaccine.2017.09.092","article-title":"Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100092_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2022.02.040","article-title":"WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants\u2014key considerations for global use","author":"Sparrow","year":"2022","journal-title":"Vaccine"},{"issue":"10340","key":"10.1016\/j.jacig.2023.100092_bib4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100092_bib5","series-title":"Bringing preventive RSV monoclonal antibodies to\u00a0infants in low- and middle-income countries: challenges and opportunities","author":"Ananworanich","year":"2021"},{"key":"10.1016\/j.jacig.2023.100092_bib6","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.vaccine.2020.01.020","article-title":"Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization\u2013sponsored meeting","volume":"38","author":"Driscoll","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100092_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(20)30109-0","article-title":"Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis","volume":"8","author":"Brunwasser","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"10118","key":"10.1016\/j.jacig.2023.100092_bib8","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100092_bib9","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0000000000001167","article-title":"The impact of respiratory syncytial virus disease prevention on pediatric asthma","volume":"35","author":"Caballero","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jacig.2023.100092_bib10","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1016\/j.vaccine.2017.09.048","article-title":"Estimating the full public health value of vaccination","volume":"35","author":"Gessner","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100092_bib11","doi-asserted-by":"crossref","unstructured":"Laufer R, Baral R, Buchwald A, Campbell J, Coulibaly F, Diallo F, et\u00a0al. Optimizing next-generation RSV prevention in Mali: a cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis medRxiv, May 20, 2022. Available at: https:\/\/doi.org\/10.1101\/2022.05.19.22275309.","DOI":"10.1101\/2022.05.19.22275309"},{"key":"10.1016\/j.jacig.2023.100092_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2021.06.086","article-title":"Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: a modeling study to inform policy and investment decisions","author":"Laufer","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100092_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/cid\/ciz157","article-title":"Epidemiology, risk factors, and outcomes of respiratory syncytial virus infections in newborns in Bamako, Mali","volume":"70","author":"Buchwald","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacig.2023.100092_bib16","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1016\/S2214-109X(19)30264-5","article-title":"Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis","volume":"7","author":"Li","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacig.2023.100092_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12916-020-01537-6","article-title":"Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries","volume":"18","author":"Li","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.jacig.2023.100092_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jpids\/piaa077","article-title":"Risk of repeated admissions for respiratory syncytial virus in a cohort of >10 000 hospitalized children","volume":"10","author":"Wong","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"10311","key":"10.1016\/j.jacig.2023.100092_bib19","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(21)01450-1","article-title":"Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network phase I cross-sectional study","volume":"398","author":"Asher","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100092_bib20","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1016\/j.vaccine.2018.10.041","article-title":"Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: a sample size analysis","volume":"36","author":"Riddell","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jacig.2023.100092_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archpediatrics.2009.31","article-title":"The relative merits of risk ratios and odds ratios","volume":"163","author":"Cummings","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jacig.2023.100092_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"Griffin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100092_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.25259\/JPATS_12_2022","article-title":"Asthma care in sub-Saharan Africa: mind the gap","volume":"3","author":"Refiloe","year":"2022","journal-title":"J Pan Afr Thorac Soc"},{"key":"10.1016\/j.jacig.2023.100092_bib26","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/v13102055","article-title":"Metabolic reprogramming of nasal airway epithelial cells following infant respiratory syncytial virus infection","volume":"13","author":"Connelly","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jacig.2023.100092_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826666","article-title":"Effect of infant RSV infection on memory T cell responses at age 2-3 years","volume":"13","author":"Chirkova","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2023.100092_bib28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jaip.2021.12.005","article-title":"Long-term respiratory consequences of early-life respiratory viral infections: a pragmatic approach to fundamental questions","volume":"10","author":"Achten","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100092_bib29","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1542\/peds.2008-1146","article-title":"Antibiotic use in children is associated with increased risk of asthma","volume":"123","author":"Marra","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jacig.2023.100092_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S2213-2600(18)30055-9","article-title":"Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial","volume":"6","author":"Scheltema","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2023.100092_bib31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1211917","article-title":"Respiratory syncytial virus and recurrent wheeze in healthy preterm infants","volume":"368","author":"Blanken","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:20:16Z","timestamp":1778934016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829323000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2772829323000176"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100092","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100092"}}